The CONSORT statement: Revised recommendations for improving the quality of reports of parallel group randomized trials

BMC Medical Research Methodology

Volumn 1, Issue , 2001, Pages 1-7

  Moher, David ^a   Schulz, Kenneth F ^b   Altman, Douglas G ^c   Lepage, Leah ^d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DATA ANALYSIS; FOLLOW UP; INFORMATION PROCESSING; MEDICAL RESEARCH; RELIABILITY; REVIEW; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STANDARD;

HUMANS; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS;

EID: 3042581379     PISSN: 14712288     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2288-1-2     Document Type: Review

References (30)

1. Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408-412
2. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P: Does the quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998, 352:609-613
3. Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R: Treatment of Attention-Deficit/Hyperactivity Disorder. Evidence Report/Technology Assessment No. 11 (Prepared by McMaster University under Contract No. 290-97-0017), 2000,
4. Thornley B, Adams CE: Content and quality of 2000 controlled trials in schizophrenia over 50 years BMJ 1998, 317:1181-1184
5. Hotopf M, Lewis G, Normand C: Putting trials on trial- the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health 1997, 51:354-358
6. Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I: Size and quality of randomised controlled trials in head injury: review of published studies. BMJ 2000, 320:1308-1311
7. Begg CB, Cho MK, Eastwood S, Horton R, Moher D, Olkin I, Rennie D, Schulz KF, Simel DL, Stroup DF: Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996, 276:637-639
8. Freemantle N, Mason JM, Haines A, Eccles MP: CONSORT: an important step toward evidence-based health care. Ann Intern Med 1997, 126:81-83
9. Altman DG: Better reporting of randomized controlled trials: the CONSORT statement. BMJ 1996, 313:570-571
10. Schulz KF: The quest for unbiased research: randomized clinical trials and the CONSORT reporting guidelines. Ann Neurol 1997, 41:569-573
11. Huston P, Hoey J: CMAJ endorses the CONSORT statement. CMAJ 1996, 155:1277-1279
12. Davidoff F: News from the International Committee of Medical Journal Editors. Ann Intern Med 2000, 133:229-231
13. 2000, [http://www.consort-statement.org]
14. Moher D, Jones A, Lepage L,: Use of the CONSORT statement and quality of reports of randomized trials: a comparative before and after evaluation? JAMA 2001, 285:1992-1995
15. Egger M, Jüni P, Bartlett C,: The value of patient flow charts in reports of randomized controlled trials: bibliographic study. JAMA 2001, 285:1996-1999
16. Meinert CL: Beyond CONSORT: Need for improved reporting standards for clinical trials. JAMA 1998, 279:1487-1489
17. Chalmers I: Current Controlled Trials: an opportunity to help improve the quality of clinical research. Curr Control Trials Cardiovasc Med 2000, 1:3-8
18. Bailer JC III, Mosteller F: Guidelines for statistical reporting in articles for medical journals: amplifications and explanations. Ann Intern Med 1988, 108:266-273
19. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T,: The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine. 2001, 134:663-694
20. Elbourne DR, Campbell MK: Extending the CONSORT statement to cluster randomised trials: for discussion. Stats Med 2001, 20:489-496
21. Hollis S, Campbell F: What is meant by intention-to-treat analysis? Survey of published randomized controlled trials. BMJ 1999, 319:670-674
22. Ruiz-Canela M, Martinez-Gonzalez MA, de Irala-Estevez J: Intention-to-treat analysis is related to methodological quality. BMJ 2000, 320:1007-
23. Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB: Analysis of clinical trials by treatment actually is it really an option? Stat Med. 1991, 10:1595-1605
24. Bentzen SM: Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol. 1998, 46:5-18
25. O'Toole LB: MRC uses checklist similar to CONSORTs. BMJ 1997, 314:1127-
26. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF,: Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Lancet 1999, 354:1896-1900
27. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000, 283:2008-2012
28. Siegel JE, Weinstein MC, Russell LB, Gold MR: Recommendations for reporting cost-effectiveness analysis. JAMA 1996, 276:1339-1341
29. Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM: The Quality of Reporting in Published Cost-Utility Analyses, 1976-1997. Ann Intern Med 2000, 132:964-972
30. Altman DG: The scandal of poor medical research. BMJ 1994,308:283-284